# Commission Implementing Regulation (EU) 2020/1093 of 24 July 2020 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
The following Part D is added:
‘PART D
Allocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028
Active substance
Rapporteur Member State
Co-rapporteur Member State
Alpha-cypermethrin
FR
AT
Bacillus amyloliquefaciens subsp. plantarum strain D747
NL
SK
Bacillus amyloliquefaciens strain MBI 600
NL
SK
Beauveria bassiana strain NPP111B005
BE
RO
Beauveria bassiana strain 147
BE
RO
Bentazone
PL
EL
Bordeaux mixture
IT
PL
Chromafenozide
CZ
MT
Copper hydroxide
IT
PL
Copper oxide
IT
PL
Copper oxychloride
IT
PL
Cyantraniliprole
ES
FI
Fenpicoxamid
SE
BG
Flupyradifurone
EL
PL
Gamma-cyhalothrin
DE
ES
Halauxifen-methyl
HU
SE
Isofetamid
PT
IE
Mandestrobin
SE
NO
Meptyldinocap
HR
DE
Methoxyfenozide
FR
HU
Metschnikowia fructicola strain NRRL Y-27328
NL
HR
Oxathiapiprolin
NO
CZ
Pinoxaden
FI
BE
Propyzamide
DK
DE
Rescalure
IE
PT
Sulfoxaflor
AT
ES
Terpenoid blend QRD 460
FR
DK
Tribasic copper sulphate
IT
PL
’

---
Source: https://www.legislation.gov.uk/eur/2020/1093/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-1093/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.